Sanchez-Roige, Sandra http://orcid.org/0000-0001-6137-5699
Jennings, Mariela V.
Thorpe, Hayley H. A.
Mallari, Jazlene E.
van der Werf, Lieke C.
Bianchi, Sevim B.
Huang, Yuye
Lee, Calvin
Mallard, Travis T. http://orcid.org/0000-0002-3265-3001
Barnes, Samuel A.
Wu, Jin Yi
Barkley-Levenson, Amanda M.
Boussaty, Ely C.
Snethlage, Cedric E.
Schafer, Danielle
Babic, Zeljana
Winters, Boyer D.
Watters, Katherine E.
Biederer, Thomas http://orcid.org/0000-0003-0912-1514
Aslibekyan, Stella
Auton, Adam
Babalola, Elizabeth
Bell, Robert K.
Bielenberg, Jessica
Bryc, Katarzyna
Bullis, Emily
Coker, Daniella
Partida, Gabriel Cuellar
Dhamija, Devika
Das, Sayantan
Filshtein, Teresa
Fletez-Brant, Kipper
Freyman, Will
Heilbron, Karl
Gandhi, Pooja M.
Hicks, Barry
Hinds, David A.
Jewett, Ethan M.
Jiang, Yunxuan
Kukar, Katelyn
Lin, Keng-Han
Lowe, Maya
McCreight, Jey C.
McIntyre, Matthew H.
Micheletti, Steven J.
Moreno, Meghan E.
Mountain, Joanna L.
Nandakumar, Priyanka
Noblin, Elizabeth S.
O’Connell, Jared
Petrakovitz, Aaron A.
Poznik, G. David
Schumacher, Morgan
Shastri, Anjali J.
Shelton, Janie F.
Shi, Jingchunzi
Shringarpure, Suyash
Tran, Vinh
Tung, Joyce Y.
Wang, Xin
Wang, Wei
Weldon, Catherine H.
Wilton, Peter
Hernandez, Alejandro
Wong, Corinna
Tchakouté, Christophe Toukam
Mackillop, James http://orcid.org/0000-0003-4118-9500
Stephens, David N.
Elson, Sarah L.
Fontanillas, Pierre
Khokhar, Jibran Y. http://orcid.org/0000-0002-2169-2275
Young, Jared W.
Palmer, Abraham A.
,
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (DP1DA054394, P50DA037844, DA018928)
Tobacco-Related Disease Research Program (28IR-0070, T29KT0526 and T32IR5226, T29KT0526 and T32IR5226, T29KT0526 and T32IR5226, T29KT0526, 28IR-0070)
Brain Research Foundation (grant 27676)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (K99AA027835)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
Article History
Received: 4 April 2023
Revised: 17 April 2023
Accepted: 25 April 2023
First Online: 12 May 2023
Competing interests
: MVJ, SBB, YH, SSR and AAP were supported by funds from the California Tobacco-Related Disease Research Program (TRDRP; Grant Number 28IR-0070, T29KT0526 and T32IR5226). SBB was also supported by P50DA037844, SSR was also supported by NIH/NIDA DP1DA054394. JM and SSR were supported by the Brain and Behavior Foundation (grant 27676) and the Families for Borderline Personality Disorder Research (Beth and Rob Elliott) 2018 NARSAD Young Investigator Grant. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. SAB was supported by NIH/NIMH grants R01MH108653 and R21MH117518. AMBL was supported by NIH/NIAAA grant K99AA027835. TB acknowledges support by NIH/NIDA R01 DA018928. JM is supported by the Peter Boris Chair in Addictions Research. HHAT is funded through a Natural Science and Engineering Research Council PGS-D scholarship, and studies in Cohort 2 were supported by the Canadian Institutes of Health Research Project Grant (PJT-173442 to JYK). PF and SLE are employees of 23andMe, Inc., and hold stock or stock options in 23andMe. JY reports having received grant support funding from Sunovion, Heptares, and Gilgamesh, as well as honoraria from Marvel Biotech, none of which were involved in the current project. The other authors report no conflict of interest.